English
中文
English
中文
Home
About Us
Company Introduction
Corporate Culture
Company Team
Development History
Products
Listed Products
Products Under Development
Technology
Scientific Research Achievements
R & D Platform
Quality System
News
Company News
Industry News
Regulatory Dynamics
Human resources
Talent Concept
Personnel Training
Career Development
Recruitment Position
Contact Us
Contact Information
Customer Message
Home
About Us
Products
Technology
News
Human resources
Contact Us
我公司生物制品一类新药重组人甲状旁腺素(1-84)完成Ⅰ期临床研究
Category:
公司新闻
Date:
2010-09-03
Click:
2859
Author:
kerun
我公司生物制品一类新药重组人甲状旁腺素(1-84)完成Ⅰ期临床研究。结果显示,药物安全性良好,符合人体药代动力学预期。
Previous:
“十一五”国家级“生物技术新药中试放大及分离纯化技术创新研发平台”获批
Next:
以合作促发展——记“第七届中国国际新药创制前沿技术与产业化发展高峰论坛暨项目合作洽谈会”